HK15287A - O-substituted(+)-cyanidan-3-ol derivatives,method for their preparation,as well as pharmaceutical compositions containing these compounds and their preparation - Google Patents

O-substituted(+)-cyanidan-3-ol derivatives,method for their preparation,as well as pharmaceutical compositions containing these compounds and their preparation

Info

Publication number
HK15287A
HK15287A HK152/87A HK15287A HK15287A HK 15287 A HK15287 A HK 15287A HK 152/87 A HK152/87 A HK 152/87A HK 15287 A HK15287 A HK 15287A HK 15287 A HK15287 A HK 15287A
Authority
HK
Hong Kong
Prior art keywords
preparation
cyanidan
derivatives
substituted
compounds
Prior art date
Application number
HK152/87A
Other languages
English (en)
Inventor
Alban Dr Albert
Pierre Dr Courbat
Andre Dr Weith
Original Assignee
Zyma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zyma Sa filed Critical Zyma Sa
Publication of HK15287A publication Critical patent/HK15287A/xx

Links

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B32LAYERED PRODUCTS
    • B32BLAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
    • B32B37/00Methods or apparatus for laminating, e.g. by curing or by ultrasonic bonding
    • B32B37/28Methods or apparatus for laminating, e.g. by curing or by ultrasonic bonding involving assembly of non-flat intermediate products which are flattened at a later step, e.g. tubes
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C07D311/60Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with aryl radicals attached in position 2
    • C07D311/62Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with aryl radicals attached in position 2 with oxygen atoms directly attached in position 3, e.g. anthocyanidins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/655Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
    • C07F9/6552Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a six-membered ring
    • C07F9/65522Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a six-membered ring condensed with carbocyclic rings or carbocyclic ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrane Compounds (AREA)
HK152/87A 1977-11-25 1987-02-19 O-substituted(+)-cyanidan-3-ol derivatives,method for their preparation,as well as pharmaceutical compositions containing these compounds and their preparation HK15287A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH1447977 1977-11-25
CH293778 1978-03-17

Publications (1)

Publication Number Publication Date
HK15287A true HK15287A (en) 1987-02-27

Family

ID=25691766

Family Applications (1)

Application Number Title Priority Date Filing Date
HK152/87A HK15287A (en) 1977-11-25 1987-02-19 O-substituted(+)-cyanidan-3-ol derivatives,method for their preparation,as well as pharmaceutical compositions containing these compounds and their preparation

Country Status (21)

Country Link
US (2) US4255336A (xx)
EP (2) EP0039844A3 (xx)
JP (1) JPS5481274A (xx)
AT (1) AT364835B (xx)
AU (1) AU526985B2 (xx)
CA (1) CA1171423A (xx)
CS (1) CS228112B2 (xx)
DD (2) DD141833A5 (xx)
DE (1) DE2862384D1 (xx)
DK (1) DK525778A (xx)
ES (2) ES475338A1 (xx)
FI (1) FI783593A (xx)
HK (1) HK15287A (xx)
IE (1) IE48250B1 (xx)
IL (1) IL56030A (xx)
MY (1) MY8700725A (xx)
NO (2) NO152651C (xx)
NZ (1) NZ189011A (xx)
PL (1) PL120640B1 (xx)
SG (1) SG82886G (xx)
YU (1) YU41030B (xx)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4285964A (en) * 1979-08-30 1981-08-25 Continental Pharma Salts of (+)-catechine, their preparation and use, and compositions containing these salts
DE3176349D1 (en) * 1980-04-03 1987-09-17 Zyma Sa Use of o-substituted derivatives of (+)-cyanidanol-3 as compounds with immunomodulative properties
GB2122608B (en) * 1982-06-01 1985-10-02 Zyma Sa (+)-cyanidan-3-ol derivatives
GB2122987B (en) * 1982-06-01 1985-09-25 Zyma Sa (+)-cyanidan-3-ol derivatives and pharmaceutical preparations thereof
DE3715779A1 (de) * 1987-05-12 1988-11-24 Kali Chemie Pharma Gmbh Flavon-3-carbonsaeure-verbindungen sowie verfahren, zwischenprodukte zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
JP3165279B2 (ja) * 1993-03-29 2001-05-14 三井農林株式会社 3−アシル化カテキンを含有する油溶性抗酸化剤
FR2706478B1 (fr) * 1993-06-14 1995-09-08 Ovi Sa Compositions de dérivés phénoliques, leur préparation et leurs applications comme anti-oxydants.
FR2728563B1 (fr) * 1994-12-21 1997-07-18 Ovi Sa Esters de composes polyhydroxyles aromatiques, leur preparation et leurs applications
US6207842B1 (en) * 1997-10-09 2001-03-27 Mars Incorporated Process for preparing procyanidin(4-6 or 4-8) oligomers and their derivatives
AU8627798A (en) * 1998-06-18 2000-01-05 Consiglio Nazionale Delle Ricerche Biocatalytic process for the preparation of 3-0-acyl-flavonoids
US6156912A (en) * 1999-04-09 2000-12-05 Mars, Incorporated 88, 66, and 68 catechin and epicatechin dimers and methods for their preparation
US7015338B1 (en) 1999-04-15 2006-03-21 Mars Incorporated Synthetic methods for preparing procyanidin oligomers
US6476241B1 (en) 2000-09-05 2002-11-05 Mars Incorporated Synthesis of 4α-arylepicatechins
US7067679B2 (en) * 2002-10-02 2006-06-27 Mars, Inc. Synthesis of dimeric, trimeric, tetrameric pentameric, and higher oligomeric epicatechin-derived procyanidins having 4,8-interflavan linkages and their use to inhibit cancer cell growth through cell cycle arrest
US7122573B2 (en) * 2002-12-06 2006-10-17 Sri International Analogs of green tea polyphenols as chemotherapeutic and chemopreventive agents
KR20060082790A (ko) * 2003-06-20 2006-07-19 코그니스 프랑스 에스.에이.에스. ω-치환된 C6-C22 지방산을 갖는 플라보노이드의에스테르
TW200505468A (en) * 2003-08-11 2005-02-16 Suntory Ltd Agent for improving hepato-bililary dysfunction
AU2003267173B2 (en) * 2003-09-12 2009-09-10 Mitsui Norin Co., Ltd Antimicrobial compositions and methods of use
EP1763360A4 (en) * 2004-04-02 2009-08-19 Ind Res Ltd L L C FRUIT EXTRACTS FROM PASSION AND USES THEREOF
CN101018793A (zh) * 2004-09-14 2007-08-15 味之素欧姆尼凯姆股份有限公司 作为颜色稳定剂的磷酰化多酚
EP1797055A4 (en) * 2004-09-22 2009-11-11 Indspec Chemical Corp IGNIFUGES IN THE FORM OF PHOSPHATE ESTERS OBTAINED FROM RESORCINOL-KETONE REACTION PRODUCTS
WO2006080328A1 (ja) * 2005-01-26 2006-08-03 Suntory Limited カテキン類のエステル化物、その製造方法、および該エステル化物を含む飲食品あるいは化粧品
US20070004796A1 (en) * 2005-06-29 2007-01-04 Romanczyk Leo Jr Processes for the preparation of protected-(+)-catechin and (-)-epicatechin monomers, for coupling the protected monomers with an activated, protected epicatechin monomer, and for the preparation of epicatechin-(4B,8)-epicatechin or -catechin dimers and their digallates
CN106565658A (zh) * 2016-10-21 2017-04-19 浙江大学 3‑硫酸基儿茶素的制备方法
EP4431169A1 (en) 2023-03-17 2024-09-18 Siegfried AG Method of purifying cannabinoid components from plant extracts

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2861992A (en) * 1955-08-29 1958-11-25 Rech S Et Tech Appliquees Derivatives of quercetin and to prodesses for their preparation
US3314975A (en) * 1963-01-25 1967-04-18 Jurd Leonard Flavylium compounds and methods of using them
FR7760M (xx) * 1968-11-22 1970-03-16
US3661890A (en) * 1970-03-10 1972-05-09 Us Agriculture Preparation of quercetin derivatives
CH514574A (fr) * 1970-03-13 1971-10-31 Zyma Sa Procédé de fabrication de sels des acides épicatéchine sulfoniques-2
FR2128207B1 (xx) * 1971-03-11 1974-08-02 Zyma Sa
GB1575004A (en) * 1976-03-23 1980-09-17 Iverni Della Beffa Spa Pharmacologically active polyphenolic substances
DE2740346C2 (de) * 1976-09-08 1987-02-05 Inverni Della Beffa S.P.A., Mailand/Milano Pharmazeutische Zubereitung mit narbenbildender, Epithelium-regenerierender, entzündungshemmender, gefäßschützender, hypolipämischer, hypocholesterinämischer und/oder hypoglykämischer Wirkung

Also Published As

Publication number Publication date
IL56030A (en) 1985-08-30
NZ189011A (en) 1981-01-23
DK525778A (da) 1979-05-26
AU4187778A (en) 1979-05-31
IE48250B1 (en) 1984-11-14
US4617296A (en) 1986-10-14
YU275378A (en) 1982-10-31
PL211196A1 (pl) 1979-11-19
CS228112B2 (en) 1984-05-14
YU41030B (en) 1986-10-31
PL120640B1 (en) 1982-03-31
IL56030A0 (en) 1979-01-31
DD141833A5 (de) 1980-05-21
NO830800L (no) 1979-05-28
DD148055A5 (de) 1981-05-06
ATA835678A (de) 1981-04-15
AT364835B (de) 1981-11-25
AU526985B2 (en) 1983-02-10
CA1171423A (en) 1984-07-24
EP0039844A2 (de) 1981-11-18
NO152651C (no) 1985-10-30
JPS5481274A (en) 1979-06-28
EP0039844A3 (de) 1981-11-25
EP0003274B1 (de) 1984-02-29
NO783968L (no) 1979-05-28
IE782326L (en) 1979-05-25
ES480605A1 (es) 1980-04-01
US4255336A (en) 1981-03-10
EP0003274A1 (de) 1979-08-08
NO152651B (no) 1985-07-22
SG82886G (en) 1987-07-03
FI783593A (fi) 1979-05-26
MY8700725A (en) 1987-12-31
ES475338A1 (es) 1980-03-01
DE2862384D1 (en) 1984-04-05

Similar Documents

Publication Publication Date Title
DE2862384D1 (en) O-substituted (+)-cyanidan-3-ol derivatives, method for their preparation, as well as pharmaceutical compositions containing these compounds and their preparation
DE2860900D1 (en) Triphenylalkene derivatives, process for their preparation and pharmaceutical compositions containing them
DE2965279D1 (en) Indanyl derivatives, process for their preparation and pharmaceutical compositions containing these compounds
IL55109A (en) 1-acyl-2-cyanoaziridines,process for their preparation and pharmaceutical compositions containing them
DE2861361D1 (en) 1-n-acylated-4-o-glycosyl-6-o-glycosyl-1,3-diaminocyclitol derivatives, process for their preparation and pharmaceutical compositions containing them
IL55765A0 (en) New dihydtrophyridine derivatives,their preparation and pharmaceutical compositions containing them
IL56013A0 (en) Therapeutic compositions containing naphthoquinone derivatives, certain such new compounds and their preparation
IL53857A0 (en) New aminoalkoxyphenyl derivatives, their preparation and pharmaceutical compositions containing them
IL55254A (en) Bis-isoquinolinium compounds,their preparation and pharmaceutical compositions containing them
ZA793682B (en) New piperidylbenzimidazolinone derivatives,processes for their preparation and pharmaceutical compositions containing them
DE2861767D1 (en) Cephalosprin derivatives, process for their preparation and pharmaceutical compositions containing them
DE3062972D1 (en) Pyridazopyridazine derivatives, processes for their preparation and pharmaceutical compositions containing these pyridazopyridazine derivatives
IL54576A0 (en) New chromene derivatives, their preparation and pharmaceutical compositions containing them
DE2861177D1 (en) 2-benzazepine compounds, processes for their preparation and pharmaceutical compositions containing them
IL55120A0 (en) New 3-pyridazine derivatives,their preparation and pharmaceutical compositions containing them
IL55139A (en) Substituted 2-cyclopropyl-chromones,process for their preparation and pharmaceutical compositions containing them
DE2860212D1 (en) 4-phenyl-8-amino-tetrahydroisoquinolines, pharmaceutical compositions containing them and process for preparation of these compositions
ZA782432B (en) 2-benzyl-perhydroazepines,process for their preparation and pharmaceutical compositions containing them
ZA785769B (en) Piperidine compounds,processes for their preparation,and pharmaceutical compositions comprising these compounds
IL52207A (en) Substituted 2-vinyl-chromones, process for their preparation and pharmaceutical compositions containing them
DE2860861D1 (en) Piperazino-pyrrolobenzodiazepines, methods for their preparation and pharmaceutical compositions containing them
IL53948A0 (en) New thiazinoindole derivatives, their preparation and pharmaceutical compositions containing them
IL55352A0 (en) New 3-amino-17a-aza-d-homoandrostane derivatives, their preparation and pharmaceutical compositions containing them
DE2860471D1 (en) Derivatives of benzenesulfonamide, method for their preparation and pharmaceutical compositions containing them
IL54308A (en) 9-fluoroprednisolone derivatives,process for their preparation and pharmaceutical compositions containing them